Literature DB >> 16421640

[Pneumocystis jiroveci pneumonia (PcP) in patients with rheumatic diseases: case report and review].

B Bertisch1, C Ruef.   

Abstract

A 74-year-old female patient with rheumatoid arthritis was diagnosed with Pneumocystis jiroveci pneumonia (PcP) following therapy with methotrexate and prednisone. Although bactrim treatment was initiated and PcP was not detected by a control bronchoalveolar lavage, the patient died. The precise cause of death remains unknown. As this case illustrates, PcP must be considered as a differential diagnosis in immunocompromised patients with rheumatic disease. The typical course, diagnosis, prophylaxis and treatment of PcP in this patient group are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16421640     DOI: 10.1007/s00393-005-0019-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  25 in total

1.  Pulmonary coinfection by Pneumocystis carinii and Aspegillus fumigatus in a seronegative arthritis patient treated with low-dose methotrexate.

Authors:  M Mariñosa; A Soler; X Nogués; J Pedro-Botet
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

Review 2.  Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome.

Authors:  Kent A Sepkowitz
Journal:  Clin Infect Dis       Date:  2002-03-21       Impact factor: 9.079

3.  Nocardiosis associated with low dose methotrexate for rheumatoid arthritis.

Authors:  J M Keegan; J W Byrd
Journal:  J Rheumatol       Date:  1988-10       Impact factor: 4.666

Review 4.  Prevention of infectious complications in rheumatic disease patients: immunization, Pneumocystis carinii prophylaxis, and screening for latent infections.

Authors:  N G Singer; W J McCune
Journal:  Curr Opin Rheumatol       Date:  1999-05       Impact factor: 5.006

Review 5.  Low-dose methotrexate as a risk factor for Pneumocystis carinii pneumonia.

Authors:  S Krebs; R B Gibbons
Journal:  Mil Med       Date:  1996-01       Impact factor: 1.437

6.  Sputum induction for diagnosis of Pneumocystis carinii pneumonia.

Authors:  T R Leigh; P Parsons; C Hume; O A Husain; B Gazzard; J V Collins
Journal:  Lancet       Date:  1989-07-22       Impact factor: 79.321

7.  Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies.

Authors:  J A Kovacs; J W Hiemenz; A M Macher; D Stover; H W Murray; J Shelhamer; H C Lane; C Urmacher; C Honig; D L Longo
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

8.  Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases.

Authors:  K Saito; S Nakayamada; K Nakano; M Tokunaga; S Tsujimura; K Nakatsuka; T Adachi; Y Tanaka
Journal:  Rheumatology (Oxford)       Date:  2004-02-03       Impact factor: 7.580

9.  Cryptococcosis associated with low-dose methotrexate for arthritis.

Authors:  M Altz-Smith; L G Kendall; A M Stamm
Journal:  Am J Med       Date:  1987-07       Impact factor: 4.965

10.  Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis.

Authors:  F P Ognibene; J H Shelhamer; G S Hoffman; G S Kerr; D Reda; A S Fauci; R Y Leavitt
Journal:  Am J Respir Crit Care Med       Date:  1995-03       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.